SYGNIS AG successfully completes Rights Offering and Private Placement * Rights offering and private placement significantly oversubscribed * Acquisition of Innova Biosciences Ltd. secured * Gross proceeds of EUR 10 million to cover transaction and integration costs and working capital Madrid, Spain, and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced […]
Billerica, MA, USA – Pion Inc. announced today the acquisition of Sirius Analytical Instruments Ltd., headquartered in East Sussex, United Kingdom. Building off the 2016 acquisition of Vortex’s laboratory equipment services division, acquiring Sirius continues Pion’s initiative to grow their global footprint in instrumentation and services. Now with key facilities in both North America and Europe, […]
SYGNIS AG receives binding commitment for the purchase of shares for up to EUR 3.5 million within the scope of the ongoing capital increases to finance the acquisition of Innova Biosciences Ltd. Madrid, Spain, and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today received a binding commitment for the purchase of shares […]
The main topics of this year’s Labvolution are once again entirely dedicated to the laboratory of the future. These days, digital capture and management of sample information and experimental data are increasingly gaining in significance. The Eppendorf booth, too, will be entirely networked. At this world premiere, the Eppendorf VisioNize® system will be introduced to […]
Lonza has acquired HansaBioMed Life Sciences and has invested into Exosomics Siena to develop next-generation research, therapeutic and diagnostic applications based on exosomes Exosomes technology will leverage Lonza’s portfolio of drug discovery products, as well as its development and manufacturing expertise in mammalian cell culture Basel, Switzerland – Lonza, a global leader in the field of […]
– Revolutionary computer-aided retro-synthesis software optimizes productivity, organic synthesis – Complements MilliporeSigma’s leading e-commerce platform and chemistry portfolio of more than 400,000 building blocks, catalysts and reagents for chemical synthesis This image illustrates the synthetic pathways a researcher using Chematica might be given. Each burst represents the viable reaction options. The connections between the bursts […]
– Revolutionary computer-aided retro-synthesis software optimizes productivity, organic synthesis – Complements MilliporeSigma’s leading e-commerce platform and chemistry portfolio of more than 400,000 building blocks, catalysts and reagents for chemical synthesis BILLERICA, Mass. — MilliporeSigma today announced the acquisition of Grzybowski Scientific Inventions (GSI), a company that developed the revolutionary computer-aided retro-synthesis tool, Chematica. Chematica uses advanced reaction […]
LAMPIRE Biological Laboratories, Inc., announced it has completed the acquisition of H. B. Custom Media, based out of the Ben Franklin Tech Ventures Business Center, in Bethlehem, PA. The acquisition includes all equipment, materials and personnel. LAMPIRE Biological Laboratories, Inc., is a provider of human and animal blood and blood products, OMNI C3 cell culture […]
Acquisition strengthens portfolio with best-selling labelling technology Lightning Link® Combined 2017 pro-forma revenues expected to exceed EUR 10 million Acquisition to be financed by way of a rights issue and a private placement excluding pre-emptive rights with total proceeds of up to EUR 10 mio Two million shares to be offered to Innova shareholders as […]
Successful exit just 1.5 years after the Company’s founding proves investment rationale Heidelberg, Germany – EMBL Ventures today announced that it has sold its portfolio company Luxendo to Bruker (NASDAQ: BRKR). EMBL Ventures was lead investor with LSP in October 2015 when Luxendo was created as a spin-off by the European Molecular Biology Laboratory (EMBL) […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
